Trials / Unknown
UnknownNCT01768208
Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 569 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label, cohort study to evaluate the potential mechanisms of Saxagliptin in the treatment of patients with type 2 diabetes (T2DM) using a comprehensive metabolomic method, in combination with fingerprint analysis and target analysis. It is a sub-study of STUDY: D168L00008.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saxagliptin |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2016-12-01
- Completion
- 2017-12-01
- First posted
- 2013-01-15
- Last updated
- 2016-06-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01768208. Inclusion in this directory is not an endorsement.